Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body | Zendy

David Jacobs | Zendy; Grube | Zendy; Harry W. Flynn | Zendy; Greven | Zendy; Darlene Miller | Zendy; Robert F. Sanke | Zendy; Joseph H. Thorman | Zendy; Avinash Pathengay | Zendy

Open Access

Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body

Author(s) -

David Jacobs,

Grube,

Harry W. Flynn,

Greven,

Darlene Miller,

Robert F. Sanke,

Joseph H. Thorman,

Avinash Pathengay

Publication year - 2013

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s44212

Subject(s) - endophthalmitis , moxifloxacin , vitrectomy , medicine , ophthalmology , foreign body , vancomycin , ciprofloxacin , ceftazidime , surgery , antibiotics , pseudomonas aeruginosa , microbiology and biotechnology , visual acuity , biology , staphylococcus aureus , genetics , bacteria

A healthy 34-year-old man presented with Ochrobactrum intermedium endophthalmitis due to a metallic intraocular foreign body. After vitrectomy, lensectomy, removal of the metallic intraocular foreign body, intravitreal vancomycin and ceftazidime, and systemic ciprofloxacin, intraocular inflammation worsened. Repeat vitreous culture confirmed persistent endophthalmitis due to multidrug-resistant O. intermedium. The endophthalmitis successfully resolved after the administration of intravitreal moxifloxacin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research